e-learning
resources
Glasgow 2004
Wednesday 08.09.2004
Role of infection in COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Short-term recovery in SGRQ following a COPD exacerbation in the MOSAIC study correlates with the preceding deterioration, but is larger
P. W. Jones, S. Spencer, I. Duprat-Lomon, P. P. Sagnier, R. Wilson (London, Uxbridge, United Kingdom; Puteaux, France)
Source:
Annual Congress 2004 - Role of infection in COPD
Session:
Role of infection in COPD
Session type:
Oral Presentation
Number:
4201
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. W. Jones, S. Spencer, I. Duprat-Lomon, P. P. Sagnier, R. Wilson (London, Uxbridge, United Kingdom; Puteaux, France). Short-term recovery in SGRQ following a COPD exacerbation in the MOSAIC study correlates with the preceding deterioration, but is larger. Eur Respir J 2004; 24: Suppl. 48, 4201
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Value of measuring SGRQ at stable phase of COPD to predict the timing and deterioration associated with next exacerbation: the MOSAIC study
Source: Eur Respir J 2004; 24: Suppl. 48, 240s
Year: 2004
Short physical performance battery as a predictor of adverse outcomes following hospitalisation for an acute exacerbation of COPD
Source: International Congress 2016 – Management of dyspnoea and exacerbations in chronic lung diseases
Year: 2016
Mometasone/indacaterol/glycopyrronium (MF/IND/GLY) improves lung function and reduces exacerbations in patients with asthma, independent of baseline airflow limitation: Results from IRIDIUM study
Source: Virtual Congress 2021 – Asthma inhalers: new devices and adherence
Year: 2021
Changes in physical activity and sleep duration following hospitalisation with acute exacerbation of COPD
Source: Annual Congress 2012 - The latest insights in chronic care
Year: 2012
Early occurrence of any COPD exacerbation predicts further higher risk of moderate/severe exacerbations regardless of recording tool: the FLAME study
Source: International Congress 2017 – Management of COPD
Year: 2017
Ensifentrine added on to tiotropium significantly improves lung function, symptoms and QoL in symptomatic COPD patients regardless of baseline reversibility
Source: Virtual Congress 2020 – Clinical studies of COPD: combination inhalers and much more
Year: 2020
Long-term outcome following first clinically important deterioration in COPD
Source: International Congress 2016 – Pharmacological management of COPD
Year: 2016
The EQ-5D is responsive to recovery from a moderate COPD exacerbation
Source: Annual Congress 2009 - Quality of life and symptoms in COPD
Year: 2009
Change in clinical COPD questionnaire (CCQ) symptoms domain score and FEV
1
predict treatment failure during hospitalisation due to COPD exacerbations
Source: Eur Respir J 2007; 30: Suppl. 51, 525s
Year: 2007
Does airflow limitation severity in stable condition severity of COPD influences in patient cardiac autonomic modulation in COPD patients during hospitalization for exacerbation?
Source: Virtual Congress 2020 – COPD phenotypes
Year: 2020
6MWT improvement after pulmonary rehabilitation (PR) is inversely associated with degree of airflow obstruction in COPD patients. A retrospective study
Source: Annual Congress 2013 –The latest insights in exercise testing and physical inactivity
Year: 2013
Baseline symptom scores and future risk of severe exacerbation: The SPARK study
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015
Short-term HRQL deterioration during early-phase COPD exacerbation: a prospective Canadian cohort study
Source: Eur Respir J 2005; 26: Suppl. 49, 296s
Year: 2005
Daytime physical activity and sleep quality as related to patient-reported and physiological outcomes following severe COPD exacerbation
Source: Virtual Congress 2021 – Lung function evaluation and assessment of airway diseases
Year: 2021
Does the duration of symptoms pre admission influence the clinical course of the exacerbation in COPD?
Source: Eur Respir J 2004; 24: Suppl. 48, 15s
Year: 2004
Change in BODE index, exacerbation duration and hospitalisation in a cohort of COPD patients
Source: Annual Congress 2008 - Prognosis in COPD
Year: 2008
Change in the COPD assessment test (CAT) score as predictor of short-term evolution of patients admitted for an exacerbation of COPD
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Cognitive decline following an acute exacerbation of COPD (AECOPD)
Source: Virtual Congress 2020 – Investigations of COPD
Year: 2020
Both moderate and severe exacerbations accelerate physical activity decline in COPD patients
Source: Eur Respir J, 51 (1) 1702110; 10.1183/13993003.02110-2017
Year: 2018
COPD exacerbations significantly impact quality of life as measured by SGRQ-C total score: results from the FLAME study
Source: International Congress 2017 – Novel mechanisms and treatments for COPD
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept